Home > Newsletters > Drug Industry Daily > Novartis’ Nebraska Plant Powering Up, But Remediation Pain Brings Income Hit
Drug Industry Daily
July 20, 2012 | Vol. 11 No. 142
Novartis’ Nebraska Plant Powering Up, But Remediation Pain Brings Income Hit
Production at Novartis’ Lincoln, Neb., OTC drug plant has begun to ramp up “line by line, product by product,” but six months of remediation has contributed to flat 2012 sales and a 5 percent drop in operating income compared with last year, company officials say.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.